Mimedx (MDXG) Capital Expenditures (QoQ) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 100.00% |
| Dec 31, 2025 | 48.44% |
| Sep 30, 2025 | 7.26% |
| Jun 30, 2025 | -52.52% |
| Mar 31, 2025 | 43.35% |
| Dec 31, 2024 | 53.80% |
| Sep 30, 2024 | 62.86% |
| Jun 30, 2024 | -90.82% |
| Mar 31, 2024 | -42.43% |
| Dec 31, 2023 | 313.20% |
| Sep 30, 2023 | -411.71% |
| Jun 30, 2023 | -52.76% |
| Mar 31, 2023 | -5.10% |
| Dec 31, 2022 | 91.12% |
| Sep 30, 2022 | -8.16% |
| Jun 30, 2022 | 222.03% |
| Mar 31, 2022 | -63.69% |
| Dec 31, 2021 | -40.59% |
| Sep 30, 2021 | 35.06% |
| Jun 30, 2021 | -79.13% |
| Mar 31, 2021 | -9.93% |
| Dec 31, 2020 | 230.52% |
| Sep 30, 2020 | 59.02% |
| Jun 30, 2020 | -59.45% |
| Mar 31, 2020 | 45.05% |
| Dec 31, 2019 | 346.79% |
| Sep 30, 2019 | -37.85% |
| Jun 30, 2019 | -61.27% |
| Mar 31, 2019 | -64.57% |
| Dec 31, 2018 | -10.74% |
| Sep 30, 2018 | -17.11% |
| Jun 30, 2018 | -19.45% |
| Mar 31, 2018 | 172.07% |
| Dec 31, 2017 | -71.68% |
| Sep 30, 2017 | 79,560.00% |
| Jun 30, 2017 | -50.00% |
| Mar 31, 2017 | 100.19% |
| Dec 31, 2016 | -436.29% |
| Sep 30, 2016 | -11.51% |
| Jun 30, 2016 | -13.00% |
| Mar 31, 2016 | 21.62% |
| Dec 31, 2015 | -0.72% |
| Sep 30, 2015 | 42.62% |
| Jun 30, 2015 | -13.44% |
| Mar 31, 2015 | -45.44% |
| Dec 31, 2014 | 9,044.44% |
| Sep 30, 2014 | -6.90% |
| Jun 30, 2014 | -12.12% |
| Mar 31, 2014 | 101.69% |
| Dec 31, 2013 | -304.23% |
| Sep 30, 2013 | -2.44% |
| Jun 30, 2013 | 1,231.90% |
| Mar 31, 2013 | -68.73% |
| Dec 31, 2012 | 43.93% |
| Sep 30, 2012 | -31.50% |
| Dec 31, 2011 | 438.91% |
| Sep 30, 2011 | -555.32% |
| Jun 30, 2011 | -71.86% |